• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染艾滋病毒和/或慢性丙型肝炎患者的钙摄入量与骨矿物质密度

Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C.

作者信息

Temesgen Zoey B, Temesgen Zelalem, Bedimo Roger J

机构信息

University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Open Forum Infect Dis. 2025 Sep 25;12(9):ofaf562. doi: 10.1093/ofid/ofaf562. eCollection 2025 Sep.

DOI:10.1093/ofid/ofaf562
PMID:41018712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12461852/
Abstract

BACKGROUND

Increased prevalence of reduced bone mineral density (BMD) is well documented in persons infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), or both. This study's purpose was to determine if an association exists between dietary calcium intake and BMD in these patients.

METHODS

Participants were individuals with virologically suppressed HIV or untreated HCV monoinfections, those with HIV/HCV coinfection, and noninfected controls. The Hertzler-Frary dietary calcium questionnaire documented calcium intake with calcium amounts based on the US Department of Agriculture nutrient database. BMD was measured at baseline by dual-energy x-ray absorptiometry, and χ tests were used to assess the relationship between BMD and infection status. One-way analysis of covariance was used to compare calcium intake data with the prevalence of normal BMD and osteoporosis by infection group. Adjustments were made for race, age, body mass index, and smoking status. Spearman correlation was used to identify relationships between calcium intake from foods/beverages and BMD.

RESULTS

A total of 452 men were recruited into the study. Osteoporosis and osteopenia were prevalent, but there was no association between infection group and BMD result ( = 6.813; = .34). Only HCV-infected patients with osteoporosis had lower calcium intake than patients with normal BMD (mean difference, 409 mg/d [95% confidence interval, 35-784 mg/d]; = .03).

CONCLUSIONS

In this study population, dietary calcium intake was correlated with reduced BMD only in patients with HCV monoinfection.

摘要

背景

骨矿物质密度(BMD)降低在感染人类免疫缺陷病毒(HIV)、丙型肝炎病毒(HCV)或同时感染这两种病毒的人群中患病率增加,这一点已有充分记录。本研究的目的是确定这些患者的膳食钙摄入量与骨矿物质密度之间是否存在关联。

方法

参与者包括病毒学抑制的HIV感染者、未经治疗的HCV单一感染者、HIV/HCV合并感染者以及未感染的对照组。赫兹勒 - 弗雷里膳食钙问卷根据美国农业部营养数据库记录钙摄入量。在基线时通过双能X线吸收法测量骨矿物质密度,并使用χ检验评估骨矿物质密度与感染状态之间的关系。使用单因素协方差分析比较各感染组的钙摄入量数据与正常骨矿物质密度和骨质疏松症的患病率。对种族、年龄、体重指数和吸烟状况进行了调整。使用斯皮尔曼相关性分析来确定食物/饮料中的钙摄入量与骨矿物质密度之间的关系。

结果

共有452名男性被纳入该研究。骨质疏松症和骨质减少很普遍,但感染组与骨矿物质密度结果之间没有关联(χ² = 6.813;P = 0.34)。只有感染HCV且患有骨质疏松症的患者的钙摄入量低于骨矿物质密度正常的患者(平均差异为409 mg/d [95%置信区间,35 - 784 mg/d];P = 0.03)。

结论

在本研究人群中,仅HCV单一感染患者的膳食钙摄入量与骨矿物质密度降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6337/12461852/344cc848b3f9/ofaf562f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6337/12461852/b6ba43c5334c/ofaf562f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6337/12461852/344cc848b3f9/ofaf562f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6337/12461852/b6ba43c5334c/ofaf562f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6337/12461852/344cc848b3f9/ofaf562f2.jpg

相似文献

1
Calcium Intake and Bone Mineral Density in People With HIV and/or Chronic Hepatitis C.感染艾滋病毒和/或慢性丙型肝炎患者的钙摄入量与骨矿物质密度
Open Forum Infect Dis. 2025 Sep 25;12(9):ofaf562. doi: 10.1093/ofid/ofaf562. eCollection 2025 Sep.
2
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
3
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
4
Calcium and vitamin D for increasing bone mineral density in premenopausal women.钙和维生素 D 增加绝经前妇女的骨密度。
Cochrane Database Syst Rev. 2023 Jan 27;1(1):CD012664. doi: 10.1002/14651858.CD012664.pub2.
5
Vesicoureteral Reflux膀胱输尿管反流
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.一项为期两年的随访研究(PRIMROSE 3),旨在评估完成PRIMROSE 1和PRIMROSE 2林扎戈利克斯试验的子宫肌瘤患者的骨矿物质密度。
Hum Reprod Open. 2025 May 13;2025(3):hoaf025. doi: 10.1093/hropen/hoaf025. eCollection 2025.
8
To explore the association between the neutrophil percentage to albumin ratio and low bone mineral density/osteoporosis based on NHANES 2011-2018.基于2011 - 2018年美国国家健康与营养检查调查(NHANES),探讨中性粒细胞百分比与白蛋白比值和低骨密度/骨质疏松症之间的关联。
Sci Rep. 2025 Aug 12;15(1):29544. doi: 10.1038/s41598-025-12732-x.
9
Treatment for osteoporosis in people with beta-thalassaemia.β-地中海贫血患者骨质疏松的治疗。
Cochrane Database Syst Rev. 2023 May 9;5(5):CD010429. doi: 10.1002/14651858.CD010429.pub3.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.

本文引用的文献

1
The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.预测 2030 年美国艾滋病毒感染者合并症和多种合并症的流行情况:一项建模研究。
PLoS Med. 2024 Jan 12;21(1):e1004325. doi: 10.1371/journal.pmed.1004325. eCollection 2024 Jan.
2
Osteoporosis and HIV Infection.骨质疏松症与HIV感染
Calcif Tissue Int. 2022 May;110(5):624-640. doi: 10.1007/s00223-022-00946-4. Epub 2022 Jan 30.
3
Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).队列简介更新:瑞士艾滋病毒队列研究(SHCS)。
Int J Epidemiol. 2022 Feb 18;51(1):33-34j. doi: 10.1093/ije/dyab141.
4
Trends of age-related non-communicable diseases in people living with HIV and comparison with uninfected controls: A nationwide population-based study in South Korea.在韩国,一项全国性基于人群的研究显示,与未感染对照人群相比,艾滋病毒感染者中非传染性疾病的年龄相关性趋势。
HIV Med. 2021 Oct;22(9):824-833. doi: 10.1111/hiv.13139. Epub 2021 Jul 14.
5
The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era.在抗逆转录病毒治疗(HAART)前、早期和晚期时代,HIV 感染者(PLHIV)中非传染性疾病的负担和死亡率。
HIV Med. 2021 Jul;22(6):478-490. doi: 10.1111/hiv.13077. Epub 2021 Feb 28.
6
Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: a cross-sectional investigation in Taiwan.台湾地区绝经后妇女丙型肝炎病毒感染与骨质疏松性骨折风险的相关性:一项横断面研究。
BMJ Open. 2019 Jan 15;9(1):e021990. doi: 10.1136/bmjopen-2018-021990.
7
Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.丙型肝炎病毒合并感染作为骨质疏松症和骨折的一个风险因素。
Curr Opin HIV AIDS. 2016 May;11(3):285-93. doi: 10.1097/COH.0000000000000259.
8
Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study.丙型肝炎病毒暴露与骨质疏松症风险之间的关系:一项基于全国人口的研究。
Medicine (Baltimore). 2015 Nov;94(47):e2086. doi: 10.1097/MD.0000000000002086.
9
Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease.人类免疫缺陷病毒和丙型肝炎病毒所致骨病的机制:骨转换、替诺福韦暴露、性激素及肝脏疾病严重程度的影响
AIDS. 2016 Feb 20;30(4):601-8. doi: 10.1097/QAD.0000000000000952.
10
Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.食用乳制品对健康的影响:益处与认知——比利时骨科学会及骨质疏松症、骨关节炎和肌肉骨骼疾病临床与经济学会欧洲分会的评论文章
Calcif Tissue Int. 2016 Jan;98(1):1-17. doi: 10.1007/s00223-015-0062-x. Epub 2015 Oct 7.